Back
Open Access

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: pro.

Session: Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Speaker: Doctor R. Al-Lamee (London, GB)
Event: ESC Congress 2021 - The Digital Experience

Congress Session

0

About the speaker

Doctor Rasha Al-Lamee

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

2 more presentations in this session

Revascularisation is primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy: con.

Speaker: Doctor D. Holmes (Rochester, US)

Access
Slides
Video
0
Thumbnail

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy? – discussion.

Access
Video
0
Thumbnail

Access the full session

Great Debate: is revascularisation primarily intended for chronic coronary syndrome patients with symptoms refractory to medical therapy?

Speakers: Doctor R. Al-Lamee, Doctor D. Holmes
Access
Video
0
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

Related content

Open Access

Great Debate: when less is more – options to reduce the risk of bleeding after PCI – discussion.

29 August 2021

Open Access

After peripheral endovascular therapy, DAPT remains the preferred option over dual-pathway antithrombotic therapy: con.

29 August 2021

Open Access

The optimal patient pathway - how it looks like in our hospital.

28 August 2021

This platform is supported by

logo Novo Nordisk